MidFirst Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$956K Hold
6,414
– – 0.07% 173
2026
Q2
$810K Hold
6,414
– – 0.06% 180
2026
Q1
$894K Sell
6,414
-2,553
-28% -$358K 0.07% 168
2025
Q4
$1.1M Buy
+8,967
New +$1.09M 0.09% 161

Other funds holding GILD

MidFirst Bank's GILD Position: Q3 2026 in Review

MidFirst Bank held its Gilead Sciences (GILD) position steady in Q3 2026 at 6,414 shares worth $956K. The position accounts for 0.07% of the portfolio, ranked #173.

MidFirst Bank first reported a position in GILD in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.1M in Q4 2025. 2,357 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • MidFirst Bank held 6,414 shares of Gilead Sciences worth $956K as of Q3 2026.
  • MidFirst Bank left its Gilead Sciences share count unchanged in Q3 2026.
  • Gilead Sciences made up 0.07% of MidFirst Bank's portfolio in Q3 2026, its #173 holding.
  • MidFirst Bank first reported a position in Gilead Sciences in Q4 2025 and has held it in 4 quarters since.
  • MidFirst Bank's Gilead Sciences position peaked at $1.1M in Q4 2025.
  • 2,357 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on MidFirst Bank's 13F filing for Q3 2026, filed 16 Nov 2026.